Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Megakaryocytes | 6 | 2018 | 29 | 1.950 |
Why?
|
| Organelle Biogenesis | 2 | 2016 | 10 | 1.090 |
Why?
|
| Wnt Signaling Pathway | 2 | 2016 | 54 | 1.020 |
Why?
|
| MicroRNAs | 4 | 2018 | 280 | 0.710 |
Why?
|
| Lithium Chloride | 1 | 2016 | 2 | 0.550 |
Why?
|
| Frizzled Receptors | 1 | 2016 | 3 | 0.540 |
Why?
|
| Interleukin-12 | 1 | 2016 | 17 | 0.530 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2016 | 29 | 0.530 |
Why?
|
| Interleukin-6 | 1 | 2016 | 189 | 0.470 |
Why?
|
| Mitochondria | 1 | 2016 | 334 | 0.440 |
Why?
|
| Insulin | 2 | 2021 | 310 | 0.340 |
Why?
|
| Thrombopoiesis | 2 | 2018 | 6 | 0.270 |
Why?
|
| Up-Regulation | 2 | 2016 | 240 | 0.240 |
Why?
|
| Endoribonucleases | 1 | 2021 | 9 | 0.190 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 16 | 0.190 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 10 | 0.190 |
Why?
|
| PPAR gamma | 1 | 2021 | 29 | 0.190 |
Why?
|
| Protective Agents | 1 | 2021 | 17 | 0.190 |
Why?
|
| Bystander Effect | 1 | 2021 | 16 | 0.190 |
Why?
|
| Indoles | 1 | 2021 | 98 | 0.180 |
Why?
|
| Carcinogenesis | 1 | 2021 | 76 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 96 | 0.180 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 247 | 0.180 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 133 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 121 | 0.160 |
Why?
|
| Humans | 11 | 2021 | 26829 | 0.160 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 58 | 0.140 |
Why?
|
| Blood Platelet Disorders | 1 | 2016 | 10 | 0.140 |
Why?
|
| Inflammation | 1 | 2021 | 601 | 0.140 |
Why?
|
| Biomimetic Materials | 1 | 2016 | 20 | 0.140 |
Why?
|
| Fetal Blood | 1 | 2016 | 37 | 0.130 |
Why?
|
| Erythrocytes | 1 | 2016 | 83 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 144 | 0.130 |
Why?
|
| Infant, Newborn | 2 | 2016 | 843 | 0.130 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 200 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 310 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 586 | 0.120 |
Why?
|
| Breeding | 1 | 2014 | 10 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2014 | 12 | 0.120 |
Why?
|
| Chickens | 1 | 2014 | 59 | 0.120 |
Why?
|
| DNA, Catalytic | 1 | 2014 | 3 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 278 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 113 | 0.110 |
Why?
|
| Cell Line | 1 | 2016 | 673 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2014 | 152 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 194 | 0.110 |
Why?
|
| Cell Proliferation | 1 | 2016 | 771 | 0.110 |
Why?
|
| Animals | 7 | 2021 | 9963 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2014 | 205 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2013 | 203 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 657 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2014 | 1344 | 0.080 |
Why?
|
| Adult | 2 | 2016 | 7383 | 0.070 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 623 | 0.070 |
Why?
|
| Neoplasms | 1 | 2014 | 755 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2018 | 395 | 0.060 |
Why?
|
| Mice | 2 | 2021 | 4408 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2021 | 20 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 9 | 0.050 |
Why?
|
| 3T3-L1 Cells | 1 | 2021 | 27 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 57 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2021 | 36 | 0.050 |
Why?
|
| Dysbiosis | 1 | 2021 | 15 | 0.050 |
Why?
|
| Ligands | 1 | 2021 | 168 | 0.050 |
Why?
|
| HEK293 Cells | 1 | 2021 | 172 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2021 | 165 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2021 | 970 | 0.040 |
Why?
|
| RNA, Untranslated | 1 | 2018 | 9 | 0.040 |
Why?
|
| Apoptosis | 1 | 2021 | 739 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 322 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 81 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 817 | 0.040 |
Why?
|
| Histones | 1 | 2018 | 90 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2016 | 12 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1476 | 0.030 |
Why?
|
| Thrombopoietin | 1 | 2016 | 17 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2018 | 148 | 0.030 |
Why?
|
| G1 Phase | 1 | 2015 | 15 | 0.030 |
Why?
|
| Obesity | 1 | 2021 | 650 | 0.030 |
Why?
|
| S Phase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 408 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 49 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Disease Resistance | 1 | 2014 | 18 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 31 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2014 | 32 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2014 | 54 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 394 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2014 | 116 | 0.030 |
Why?
|
| Cytokines | 1 | 2014 | 438 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2014 | 509 | 0.020 |
Why?
|
| Male | 1 | 2015 | 12870 | 0.010 |
Why?
|
| Female | 1 | 2015 | 14463 | 0.010 |
Why?
|